Advanced Clinic
Ikebukuro Clinic
池袋クリニック
Medical Supporter coordinates care; we are not a hospital or clinic. The institution provides diagnosis and treatment.
Key Takeaways
Kihoukai Ikebukuro Clinic is located in Minami-Ikebukuro. The current official site focuses on self-pay NK-cell therapy, iNKT therapy, alpha-beta T-cell therapy, dendritic-cell therapy, autologous cancer vaccine therapy, and high-dose vitamin C infusion. The clinic publicly lists regenerative-medicine plan numbers for Ikebukuro. Older TRAIL or cancer gene therapy materials require direct confirmation and should not be described as current core services or guaranteed treatments.
- •Location：Located in Toshima-ku, Tokyo
- •Coordination Relationship：Case-by-case coordination
Costs, the number of sessions, and the main risks and side effects of any self-pay (non-insured) treatments listed on this page vary by person; please confirm directly with the institution before your visit. Suitability must be decided by a physician.
Medical Features & Strengths
- NK, iNKT, and alpha-beta T-cell therapy
- Dendritic-cell and autologous cancer vaccine therapy
- High-dose vitamin C and supportive self-pay options
- Public regenerative-medicine plan numbers for Ikebukuro
- Older TRAIL/gene therapy materials require current confirmation
- No.15 Nohagi Building 7F, Minami-Ikebukuro
Departments & Specialties
Detailed Information
Kihokai Ikebukuro Clinic is presented by current official materials as a cancer clinic offering immune-cell therapy consultation, including NK cells, alpha-beta T cells and dendritic-cell related options.
Regenerative medicine plan listings, TRAIL-related legacy wording and cancer gene therapy terms should be handled carefully. Availability, indication, sample needs, culture schedule and risks must be confirmed from current official materials.
Clinic positioning
Regenerative medicine plan listings, TRAIL-related legacy wording and cancer gene therapy terms should be handled carefully. Availability, indication, sample needs, culture schedule and risks must be confirmed from current official materials.
Therapies confirmable from current official materials
Regenerative medicine plan listings, TRAIL-related legacy wording and cancer gene therapy terms should be handled carefully. Availability, indication, sample needs, culture schedule and risks must be confirmed from current official materials.
If standard treatment remains indicated, this page should not encourage delaying or stopping it. Discussion should start from the existing medical record, the treating physician's plan, imaging and the patient's general condition.
Regenerative medicine plans
Regenerative medicine plan listings, TRAIL-related legacy wording and cancer gene therapy terms should be handled carefully. Availability, indication, sample needs, culture schedule and risks must be confirmed from current official materials.
If standard treatment remains indicated, this page should not encourage delaying or stopping it. Discussion should start from the existing medical record, the treating physician's plan, imaging and the patient's general condition.
How to handle TRAIL and cancer gene therapy wording
Regenerative medicine plan listings, TRAIL-related legacy wording and cancer gene therapy terms should be handled carefully. Availability, indication, sample needs, culture schedule and risks must be confirmed from current official materials.
If standard treatment remains indicated, this page should not encourage delaying or stopping it. Discussion should start from the existing medical record, the treating physician's plan, imaging and the patient's general condition.
Documents to organize before consultation
For Kihokai Ikebukuro Clinic, Medical Supporter should confirm current information with the clinic before referral: indication, eligibility, required documents, self-pay fees, language support, schedule and the response plan if adverse events occur after the patient returns home.
Fees and self-pay notes
TRAIL or immune-cell therapy must not be presented as a confirmed gene-therapy service or as a treatment that can replace standard therapy without physician judgment.
Basic information
Patients should prepare pathology, imaging, treatment history, blood tests, medication list, infection status and the current treating physician’s plan before document review.
Compliance reminder
TRAIL or immune-cell therapy must not be presented as a confirmed gene-therapy service or as a treatment that can replace standard therapy without physician judgment.
Official sources
Frequently Asked Questions
How can international patients book an appointment or second opinion at Ikebukuro Clinic?
International patients should first organize their records through a medical coordination agency such as Medical Supporter and confirm acceptance with the clinic. Documents, interpretation, visa support and fees are checked case by case.